Form D · Other Investment Fund
FRX Bionik, LLC
New York, NY · CIK 0001704039
Offering snapshot reported Dec 6, 2018 · SEC filing
- Reported sold
- $80K Offering amount: $80K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 21, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 6, 2018 | Initial | $80,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06c, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-327278
Source: Form D, filed Dec 6, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Llc Assure Fund Management Ii | Executive |
| Llc Fund Rx Capital Management | Director |
| Richard Thoms | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
43 W 23rd St 6th Floor Suite 400
New York, NY, 10010
New York, NY, 10010